101 related articles for article (PubMed ID: 20159366)
1. Equivalence in dose fall-off for isocentric and nonisocentric intracranial treatment modalities and its impact on dose fractionation schemes.
Ma L; Sahgal A; Descovich M; Cho YB; Chuang C; Huang K; Laperriere NJ; Shrieve DC; Larson DA
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):943-8. PubMed ID: 20159366
[TBL] [Abstract][Full Text] [Related]
2. Comparative analyses of linac and Gamma Knife radiosurgery for trigeminal neuralgia treatments.
Ma L; Kwok Y; Chin LS; Yu C; Regine WF
Phys Med Biol; 2005 Nov; 50(22):5217-27. PubMed ID: 16264249
[TBL] [Abstract][Full Text] [Related]
3. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
Lunsford LD; Flickinger JC; Larson D
Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
[TBL] [Abstract][Full Text] [Related]
4. Hypofractionation regimens for stereotactic radiotherapy for large brain tumors.
Yuan J; Wang JZ; Lo S; Grecula JC; Ammirati M; Montebello JF; Zhang H; Gupta N; Yuh WT; Mayr NA
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):390-7. PubMed ID: 18374501
[TBL] [Abstract][Full Text] [Related]
5. Prescription dose guideline based on physical criterion for multiple metastatic brain tumors treated with stereotactic radiosurgery.
Sahgal A; Barani IJ; Novotny J; Zhang B; Petti P; Larson DA; Ma L
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):605-8. PubMed ID: 20472351
[TBL] [Abstract][Full Text] [Related]
6. Optimization of isocenter location for intensity modulated stereotactic treatment of small intracranial targets.
Salter BJ; Fuss M; Sarkar V; Wang B; Rassiah-Szegedi P; Papanikolaou N; Hollingshaus S; Shrieve DC
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):546-55. PubMed ID: 19147019
[TBL] [Abstract][Full Text] [Related]
7. Does intensity-modulated stereotactic radiotherapy achieve superior target conformity than conventional stereotactic radiotherapy in different intracranial tumours?
Sharma SD; Jalali R; Phurailatpam RD; Gupta T
Clin Oncol (R Coll Radiol); 2009 Jun; 21(5):408-16. PubMed ID: 19268555
[TBL] [Abstract][Full Text] [Related]
8. Dosimetric and radiobiological evaluation of dose distribution perturbation due to head heterogeneities for Linac and Gamma Knife stereotactic radiotherapy.
Theodorou K; Stathakis S; Lind B; Kappas C
Acta Oncol; 2008; 47(5):917-27. PubMed ID: 17957500
[TBL] [Abstract][Full Text] [Related]
9. Hypofractionated stereotactic radiotherapy using intensity-modulated radiotherapy in patients with one or two brain metastases.
Narayana A; Chang J; Yenice K; Chan K; Lymberis S; Brennan C; Gutin PH
Stereotact Funct Neurosurg; 2007; 85(2-3):82-7. PubMed ID: 17167236
[TBL] [Abstract][Full Text] [Related]
10. Peripheral dose in ocular treatments with CyberKnife and Gamma Knife radiosurgery compared to proton radiotherapy.
Zytkovicz A; Daftari I; Phillips TL; Chuang CF; Verhey L; Petti PL
Phys Med Biol; 2007 Oct; 52(19):5957-71. PubMed ID: 17881812
[TBL] [Abstract][Full Text] [Related]
11. High-precision volume-staged Gamma Knife surgery and equivalent hypofractionation dose schedules for treating large arteriovenous malformations.
Fogh S; Ma L; Gupta N; Sahgal A; Nakamura JL; Barani I; Sneed PK; McDermott M; Larson DA
J Neurosurg; 2012 Dec; 117 Suppl():115-9. PubMed ID: 23205798
[TBL] [Abstract][Full Text] [Related]
12. Impact of millimeter-level margins on peripheral normal brain sparing for gamma knife radiosurgery.
Ma L; Sahgal A; Larson DA; Pinnaduwage D; Fogh S; Barani I; Nakamura J; McDermott M; Sneed P
Int J Radiat Oncol Biol Phys; 2014 May; 89(1):206-13. PubMed ID: 24725703
[TBL] [Abstract][Full Text] [Related]
13. The option of Linac-based radiosurgery in a Gamma Knife radiosurgery center.
Stern RL; Perks JR; Pappas CT; Boggan JE; Chen AY
Clin Neurol Neurosurg; 2008 Dec; 110(10):968-72. PubMed ID: 18617321
[TBL] [Abstract][Full Text] [Related]
14. The impact of whole-brain radiation therapy on the long-term control and morbidity of patients surviving more than one year after gamma knife radiosurgery for brain metastases.
Varlotto JM; Flickinger JC; Niranjan A; Bhatnagar A; Kondziolka D; Lunsford LD
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1125-32. PubMed ID: 15990018
[TBL] [Abstract][Full Text] [Related]
15. Hypofractionated stereotactic radiotherapy for brain metastases--results from three different dose concepts.
Fahrig A; Ganslandt O; Lambrecht U; Grabenbauer G; Kleinert G; Sauer R; Hamm K
Strahlenther Onkol; 2007 Nov; 183(11):625-30. PubMed ID: 17960338
[TBL] [Abstract][Full Text] [Related]
16. Estimation of errors associated with use of linear-quadratic formalism for evaluation of biologic equivalence between single and hypofractionated radiation doses: an in vitro study.
Iwata H; Shibamoto Y; Murata R; Tomita N; Ayakawa S; Ogino H; Ito M
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):482-8. PubMed ID: 19735872
[TBL] [Abstract][Full Text] [Related]
17. Comparison of (125)I stereotactic brachytherapy and LINAC radiosurgery modalities based on physical dose distribution and radiobiological efficacy.
Viola A; Major T; Julow J
Radiat Res; 2006 Jun; 165(6):695-702. PubMed ID: 16802870
[TBL] [Abstract][Full Text] [Related]
18. Improvement in dose homogeneity with electronic tissue compensation over IMRT and conventional RT in whole brain radiotherapy.
Goyal S; Yue NJ; Millevoi R; Kagan E; Haffty B; Narra V
Radiother Oncol; 2008 Aug; 88(2):196-201. PubMed ID: 18362037
[TBL] [Abstract][Full Text] [Related]
19. Reirradiation tolerance of the human brain.
Mayer R; Sminia P
Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1350-60. PubMed ID: 18037587
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous beam geometry and intensity map optimization in intensity-modulated radiation therapy.
Lee EK; Fox T; Crocker I
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):301-20. PubMed ID: 16289912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
